The University of Chicago Header Logo

Connection

Lucy Godley to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications Lucy Godley has written about Histone Deacetylase Inhibitors.
Lucy Godley
Connection Strength
0.372
Histone Deacetylase Inhibitors
  1. Mutant RUNX1 and histone tales. Blood. 2017 11 16; 130(20):2156-2157.
    View in: PubMed
    Score: 0.151
  2. A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
    View in: PubMed
    Score: 0.123
  3. The use of hypomethylating agents in the treatment of hematologic malignancies. Leuk Lymphoma. 2007 Sep; 48(9):1676-95.
    View in: PubMed
    Score: 0.075
  4. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines. BMC Cancer. 2010 Jun 14; 10:286.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.